百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

交易中 05-28 10:54:57

177.100

-3.500

-1.94%

最高184.100	最低176.600	成交量101.59万
今开184.100	昨收180.600	日振幅4.15%
总市值2,729亿	流通市值2,525亿	总股本15.41亿
成交额1.83亿	换手率0.07%	流通股本14.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":177.1,"timestamp":1779936869456,"preClose":180.6,"halted":0,"volume":1015900,"delay":0,"changeRate":-0.01937984496124031,"floatShares":1426000000,"shares":1541000000,"eps":1.4880952380952384,"marketStatus":"交易中","change":-3.5,"latestTime":"05-28 10:54:57","open":184.1,"high":184.1,"low":176.6,"amount":182880522,"amplitude":0.041528,"askPrice":177.1,"askSize":23900,"bidPrice":177,"bidSize":6200,"shortable":3,"etf":0,"ttmEps":2.653336466165414,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1779940800000},"marketStatusCode":2,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":180.6,"openAndCloseTimeList":[[1779931800000,1779940800000],[1779944400000,1779955200000]],"volumeRatio":0.794435,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":233.65,"timestamp":1779936897000,"preClose":239.38,"halted":0,"volume":1677300,"delay":0,"premium":"-34.36"},"impliedVol":0.4092,"impliedVolPercentile":0.5814},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2638630243","title":"上药控股与百济神州举行战略合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2638630243","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638630243?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:32","pubTimestamp":1779928320,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，据上药控股消息，5月27日下午，上药控股与百济神州举行战略合作签约仪式，双方在医药健康领域的深度合作由此迈入全新发展阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283751977154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1719994722.HKD","BK4526","BK1161","BK4588","688235","BK4585","LU0588546209.SGD","BK1583","LU1770034418.SGD","LU0307460666.USD","LU1969619763.USD","ONC","LU1303224171.USD","LU1251922891.USD","BK1500","BK0239","BK4139","06160","LU2328871848.SGD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159250896","title":"异动解读｜百济神州盘中下跌3.07%，报181.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159250896","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159250896?lang=zh_cn&edition=full","pubTime":"2026-05-27 09:40","pubTimestamp":1779846001,"startTime":"0","endTime":"0","summary":"5月27日，百济神州盘中下跌3.07%，报181.8港元/股，成交额1.44亿港元。百济神州所在的生物科技行业中，个股中，信达生物跌0.44%，康方生物涨1.16%，派格生物医药-B跌27.04%，三生制药涨0.71%，药捷安康-B涨5.22%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7ab48a17674d5845193952fa54058c28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07200","513600","LU2328871848.SGD","LU2488822045.USD","LU0348783233.USD","688235","LU0348735423.USD","02600","LU2476274308.USD","82828","LU0540923850.HKD","03088","LU0561508036.HKD","HK0000286598.CNH","03692","09926","LU1961090484.USD","LU0348825331.USD","LU1720050803.USD","HSCI","82800","BK1161","HHImain","LU0634319403.HKD","LU1969619763.USD","BK1513","02800","LU2778985437.USD","07226","03067","BK1117","LU0588546209.SGD","LU1251922891.USD","02513","07588","LU0348767384.USD","BK1588","03417","09067","01519","LU1794554557.SGD","07300","LU2399975544.HKD","ONC","07500","00100","HSI","06160","BK1589","07552","IE00B543WZ88.USD","LU1770034418.SGD","BK1175","LU0417516902.SGD","09115","LU1303224171.USD","HSTECH","02828","03416","03423","03115","03033","BK1592","02837","HSCEI","BK1151","LU2476274720.SGD","LU0348827113.USD","BK1583","BK1191","BK1574","03419","LU1808992512.USD","LU0307460666.USD","LU0348784397.USD","02833","LU0417516571.SGD","07288","03037","83115","LU0417516738.SGD","IE00BPRC5H50.USD","09088","MCHmain","BK1500","601600","BK1568","IE00B5MMRT66.SGD","03032","LU1719994722.HKD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637399348","title":"智谱、MiniMax，有望加入恒生科技指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399348","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637399348?lang=zh_cn&edition=full","pubTime":"2026-05-22 13:38","pubTimestamp":1779428280,"startTime":"0","endTime":"0","summary":"　　恒生指数公司将于今日收市后公布季度检讨结果。　　市场焦点集中在智谱、MiniMax这两只AI概念股，有望被纳入恒生科技指数及综合指数。　　根据市场分析，智谱、MiniMax因近期市值大幅上升，已成为纳入恒生科技指数的最有力候选。　　至于摩根士丹利此前预期，智谱、及MiniMax将于6月纳入恒生科技指数，合计权重约5%至7%，或带动12.5亿至17.5亿美元的被动资金流入，而纳入港股通可能会在6个月内将内地持股比例提升至自由流通股的9%至20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-22/doc-inhytyys6180072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1117","BK1500","03417","LU0823426308.USD","03067","01818","LU0348825331.USD","HSTECH","LU0417516902.SGD","BK1574","LU0348767384.USD","LU1961090484.USD","LU0348783233.USD","LU0417516571.SGD","LU0650527681.SGD","MHImain","LU2476274308.USD","00100","LU2488822045.USD","07500","LU0708994859.HKD","02423","BK1544","LU0348827113.USD","BK1583","IE00BPRC5H50.USD","LU1770034418.SGD","BK1097","IE00B5MMRT66.SGD","LU1969619763.USD","LU2279701549.SGD","LU1267930573.SGD","06160","03423","ONC","LU1303224171.USD","LU0348735423.USD","BK1588","03115","HHImain","LU0588546209.SGD","09926","03037","LU0823426480.USD","IE0034224299.USD","BK1198","LU2476274720.SGD","LU0634319403.HKD","03088","LU0348784397.USD","09987","IE00B543WZ88.USD","LU0307460666.USD","BK1161","688235","LU0228659784.USD","02837","MCHmain","LU0417516738.SGD","82800","09115","LU0128525929.USD","LU2328871848.SGD","09088","LU1719994722.HKD","02513","07300","83115","07200","BK1592","LU0029864427.USD","LU1720050803.USD","LU2399975544.HKD","03033","03419","HSI","513600","LU0594300419.USD","07226","BEKE","LU2778985437.USD","YUMC","07552","BK1233","LU1251922891.USD","LU0310800379.SGD","LU0561508036.HKD","03032","LU0348766576.USD","02800","09067","LU1794554557.SGD","LU0540923850.HKD","02833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164258252","title":"异动解读｜百济神州盘中上涨3.48%，Q1业绩超预期叠加大行集体看涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1164258252","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164258252?lang=zh_cn&edition=full","pubTime":"2026-05-21 09:58","pubTimestamp":1779328699,"startTime":"0","endTime":"0","summary":"5月21日，百济神州盘中上涨3.48%，报185.2港元/股，成交额2.16亿港元。消息面上，公司Q1全球总收入15.13亿美元，同比增长35.5%，超出市场一致预期；GAAP净利润2.27亿美元，管理层将全年营收指引上调1亿美元至63亿至65亿美元。此外，新一代BCL2抑制剂百悦达获美国FDA加速批准，成为美国首款治疗复发或难治性套细胞淋巴瘤的BCL2抑制剂。花旗维持买入评级，美股目标价由430美元上调至453美元；中金维持跑赢行业评级，H股目标价250港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636140728","title":"百济神州美股盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636140728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636140728?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264777,"startTime":"0","endTime":"0","summary":"百济神州美股盘前涨超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743484856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743484856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0307460666.USD","ONC","BK4139","LU0588546209.SGD","BK1161","LU1719994722.HKD","BK1588","BK4588","BK0239","BK4526","LU1969619763.USD","LU1303224171.USD","LU1770034418.SGD","LU2328871848.SGD","BK4585","06160","BK1500","BK1583","LU1251922891.USD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163831928","title":"异动解读｜百济神州盘中上涨3.15%，Q1业绩超预期叠加大行集体看涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1163831928","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163831928?lang=zh_cn&edition=full","pubTime":"2026-05-20 15:03","pubTimestamp":1779260627,"startTime":"0","endTime":"0","summary":"5月20日，百济神州盘中上涨3.15%，报180.3港元/股，成交额6.06亿港元。消息面上，公司Q1财报表现强劲，全球总收入15.13亿美元，同比增长35.5%，超出市场一致预期；GAAP净利润2.27亿美元，自由现金流1.61亿美元。管理层将全年营收指引上调1亿美元至63亿至65亿美元。多家大行集体看涨，中金维持跑赢行业评级，H股目标价250港元；花旗维持买入评级，美股目标价由430美元上调至453美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636145813","title":"港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636145813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636145813?lang=zh_cn&edition=full","pubTime":"2026-05-20 13:58","pubTimestamp":1779256684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.23%，报178.7港元，成交额4.67亿港元。此前，百济神州披露26Q1业绩，中金指出，收入15.13亿美元，同比增长35%，其中产品收入14.87亿美元，同比增长34%，GAAP净利润2.27亿美元，同比增加2.26亿美元，销售收入符合该行预期，净利润超该行预期，主因费用控制较好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1303224171.USD","VXUS","BK4588","BK4585","BK4526","BK4139","06160","LU1251922891.USD","LABU","LU1770034418.SGD","BK1588","LU1969619763.USD","BK1161","688235","BK1500","LU2328871848.SGD","ONC","LU0307460666.USD","BK1583","LU0588546209.SGD","LU1719994722.HKD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636030884","title":"【券商聚焦】招银国际：AI有望改变创新药研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2636030884","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636030884?lang=zh_cn&edition=full","pubTime":"2026-05-19 13:13","pubTimestamp":1779167581,"startTime":"0","endTime":"0","summary":"当前，监管框架持续完善，传统药企与AI原生公司加速合作，AI制药正处于从研发提效工具迈向创新药研发范式重构的转折期。AI重构药物研发全链条，早期效率红利已率先显现。传统创新药研发长期受困于高成本、长周期和低成功率，AI技术正在改变靶点发现、分子筛选与优化等关键环节的研发范式。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981743","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU0067412154.USD","IE00B031HY20.USD","LU1960683339.HKD","LU0572944931.SGD","06185","09926","LU0315179316.USD","LU1226287792.SGD","06160","BK1589","AGIX","01093","AIPO","02269","09995","LU0417516738.SGD","LU1719994722.HKD","01177","LU1152091168.USD","01801","LU1226288170.HKD","159992","IE00BPRC5H50.USD","BK1583","CHAT","SG9999002562.SGD","LU0072913022.USD","LU0456846285.SGD","02616","02142","LU0516422952.EUR","LU1993786604.SGD","LU1303224171.USD","09688","LU0561508036.HKD","01877","LU0456827905.SGD","LU0348827113.USD","LU1880383366.USD","LU0348767384.USD","ARTY","LU0140636845.USD","LU0634319403.HKD","BK1588","BK1161","LU1152091754.HKD","LU0856984785.SGD","LU0326950275.SGD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","BK1576","LU0823426308.USD","02268","LU1242518931.SGD","06990","SG9999014674.SGD","LU0708995583.HKD","LU0052750758.USD","LU0348825331.USD","06160","LU0417516902.SGD","BK1574","LU0307460666.USD","XBI","ONC","LU1251922891.USD","01548","LU0181495838.USD","LU3063872942.SGD","02269","BK1161","IE00B0JY6N72.USD","LU1303224171.USD","09969","688235","BK1583","BK4588","LU0417516738.SGD","LU0516422366.SGD","161726","LU0516422440.USD","LU0359202008.SGD","BK1588","HK0000306701.USD","LU0359201612.USD","LU1770034418.SGD","HK0000320264.USD","BK1589","LU1688375341.USD","LU0588546209.SGD","LU1719994722.HKD","BK4581","BK1141","LU0043850808.USD","LU0039217434.USD","LU0456846285.SGD","399441","SG9999002562.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883343","title":"大行集体看涨百济神州(06160)，\tQ1业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883343","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883343?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:10","pubTimestamp":1779153033,"startTime":"0","endTime":"0","summary":"GAAP口径下，百济神州Q1季度全球总收入达15.13亿美元，同比增长35.5%，超出此前FactSet一致预期的14.4亿美元。26Q1季度，百济神州产品收入达15亿美元，同比增长34%。该行在将百济神州维持“买入”评级的同时，将其美股目标价由430美元进一步上调至453美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1500","BK4526","LU1251922891.USD","LU1770034418.SGD","LU0307460666.USD","LU1719994722.HKD","BK4139","LU1303224171.USD","ONC","BK4585","LU1969619763.USD","BK4588","BK1583","LU0588546209.SGD","BK0239","BK1588","688235","LU2328871848.SGD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636025578","title":"5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636025578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636025578?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:28","pubTimestamp":1779092926,"startTime":"0","endTime":"0","summary":"证券之星消息，5月18日百济神州跌5.09%，收盘报239.2元，换手率4.02%，成交量4.62万手，成交额11.12亿元。重仓百济神州的前十大公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为321.19。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。该公募基金现任基金经理为黄兴亮。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","LU2328871848.SGD","06160","BK1161","BK1588","160916","BK1500","LU1770034418.SGD","LU1251922891.USD","LU1303224171.USD","LU1969619763.USD","LU1719994722.HKD","LU0588546209.SGD","LU0307460666.USD","BK1583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023442","title":"百济神州正在接近生命周期的一次切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023442","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023442?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:13","pubTimestamp":1779092018,"startTime":"0","endTime":"0","summary":"文｜锦缎市场整体下跌时，百济神州再次成为资金流出的对象。BTK叙事的延伸一个常见的解读是，百济神州又增加了一款新药。从单品到矩阵的跃迁，本质上是公司生命周期的一次切换。索托克拉的获批，是百济神州在这条路径上迈出的一步。泽布替尼代表了百济神州的过去和现在。百济神州拿到了一张关键牌，但牌局远未到收官的阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779076618818843533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","BK1500","BK4526","LU1251922891.USD","LU1770034418.SGD","LU0307460666.USD","LU1719994722.HKD","BK4139","LU1303224171.USD","ONC","BK4585","LU1969619763.USD","BK4588","BK1583","LU0588546209.SGD","BK0239","BK1588","688235","LU2328871848.SGD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636702309","title":"美股中概股盘前涨跌互现，百度、阿里巴巴涨1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636702309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636702309?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:02","pubTimestamp":1779091355,"startTime":"0","endTime":"0","summary":"5月18日，美股中概股盘前涨跌互现，百度、阿里巴巴涨1%，京东涨0.4%，拼多多持平，网易跌0.3%，百济神州跌0.8%，携程跌1%，理想汽车跌10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740446853.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740446853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4527","LU1688375341.USD","ASHS","NTES","688235","LU0310800965.SGD","BK4531","LU0128525689.USD","MCHI","LU0348816934.USD","BK4538","LU0456842615.SGD","LU0918141887.USD","BABU","BK4554","LU1115378108.SGD","LU0949170772.SGD","LU0821914370.USD","LU1282648689.USD","LU2226246903.HKD","BIDG","BK4524","LU0640798160.USD","BK4565","82822","LU1880383366.USD","LU0553294199.USD","LU0501845795.SGD","BK4612","LU1003077747.HKD","BABW","ASHR","LU0979878070.USD","LU1242518931.SGD","XPP","LU0348814723.USD","02843","BK4552","FLCH","02822","LU0918141705.HKD","LU0963586101.USD","BK4534","09618","ALBmain","IE00BF5LJ272.USD","82843","BK4122","09988","BK4574","LU1769817096.USD","06160","LU1235294995.USD","LU1008478684.HKD","09961","LU0072913022.USD","02823","BABX","LU0359201612.USD","IE00B0JY6N72.USD","BK4504","BK4533","HXC","KBDU","BK4077","KBAB","LU1051768304.USD","BK4505","BK4550","LU0359202008.SGD","LU1023057109.AUD","LU0651947912.USD","LU0880133367.SGD","BK4514","CWEB","DRAG","LI","BK4220","LU0651946864.USD","LU1267930227.SGD","LU1046421795.USD","BABO","BK4614","BK4543","LU2148611432.USD","BBYY","BK4607","BK4588","LU0251143458.SGD","LU0738911758.USD","LU1242518857.USD","BK4502","IE00BFMHRM44.USD","LU0052756011.USD","BIDU","BK4575","LU1823568750.SGD","LU1048588211.SGD","LU1051769294.HKD","PDD","BK4585","BK4526","LU0797268264.HKD","LU1152091754.HKD","YXI","LU0067412154.USD","09999","JD","BK4581","BK4535","BK4602","BK4503","BK4548","TCOM","BK4587","LU1046422090.SGD","LU1105468828.SGD","BABA","ONC","LU0106959298.USD","LU0545039389.USD","LU1769817179.HKD","02015","LU0047713382.USD","LU0173614495.USD","09888","LU0287142896.SGD","FXP","LU1515016050.SGD","82823","LU0072462343.USD","LU1152091168.USD","LU0328353924.USD","BK4558","LU0661504455.SGD","BK4579","LU1048596156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636483820","title":"【券商聚焦】中信建投：创新药迎盈利兑现期 国内商业化与海外授权双轮驱动业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2636483820","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636483820?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:32","pubTimestamp":1779067963,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，2026年上半年医药行业触底回暖，创新药迎来盈利兑现期，国内商业化与海外授权双轮驱动业绩增长，多家企业扭亏。26Q1对外授权总额超600亿美元，ADC、双抗等前沿赛道交易持续火热。2026年ASCO年会94项中国研究中选口头报告，依沃西单抗登上全体大会，标志着中国创新药全球学术影响力迈上新台阶。国内支付端医保谈判与商保目录合力支持真创新。建议关注创新药国际化、边际改善等结构性机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981512","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1226287875.USD","LU1152091754.HKD","01177","02142","06160","601066","LU0039217434.USD","LU1242518931.SGD","LU1242518857.USD","LU1969619763.USD","LU0359202008.SGD","LU1688375341.USD","159992","01877","IE00B0JY6N72.USD","LU0979878070.USD","LU0417516738.SGD","LU2097828557.USD","LU0326950275.SGD","02616","IE00B5MMRT66.SGD","BK1141","LU0561508036.HKD","02269","LU2097828474.EUR","LU1303224171.USD","BK1588","LU2399975544.HKD","09926","LU0456827905.SGD","SG9999002562.SGD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU0348827113.USD","LU0516422952.EUR","BK1574","LU0516423174.USD","LU1152091168.USD","IE00BZ08YT58.USD","01093","01801","06185","LU2097828631.EUR","06978","IE00BZ08YS42.EUR","LU1993786604.SGD","LU0588546209.SGD","09995","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936752","title":"百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936752","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635936752?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:47","pubTimestamp":1778716032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，公司于2026年5月13日宣布百悦达获得美国食品药品监督管理局加速批准，用于治疗既往接受过至少两线系统治疗的复发或难治性(R/R)套细胞淋巴瘤成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改善用药的有效性、耐受性和便利性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1719994722.HKD","06160","BK4588","LU1770034418.SGD","LU0307460666.USD","BK4526","688235","BK4139","BK0239","LU1303224171.USD","BK1500","BK1583","LU2328871848.SGD","LABU","LU1969619763.USD","LU0588546209.SGD","BK1588","LU1251922891.USD","BK4585","ONC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01357","01833","02158","01024","02013","00772","06060","01548","02618","09992","00909","06969","00762","09699","02126","06609","00136","03888","02285","09858","09626","01905","01951","09888","09688","02276","06160","02096","03692","02171","01952","06996","02192","06186","02252","03700","02172","01060","00169","01440","06660","00719","02256","00013","06963","02197","06049","01783","81024","02306"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202523","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202523?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:04","pubTimestamp":1778663056,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年5月8日，董事会薪酬委员会根据2016期权及激励计划的条款向201名承授人授出涉及合共25,436股美国存托股份的受限制股份单位。该等受限制股份单位相当于330,668股股份，约占本公告之日公司发行股份总数的0.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1303224171.USD","BK1500","LU1770034418.SGD","BK1161","LU1719994722.HKD","BK4139","BK1583","LU0307460666.USD","BK4526","BK1588","BK4585","LU1251922891.USD","BK0239","BK4588","LU1969619763.USD","LU0588546209.SGD","06160","ONC","LU2328871848.SGD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205859","title":"中邮证券：给予百济神州买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635205859?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:05","pubTimestamp":1778655925,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈灿近期对百济神州进行研究并发布了研究报告《泽布替尼同比维持高增，全年业绩指引上调》，给予百济神州买入评级。公司为创新药出海龙头企业，全球商业化能力突出、在研管线即将进入收获期，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为321.19。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300021645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","161027","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291209","title":"百济神州(688235)3月31日股东户数3.52万户，较上期增加6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634291209?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:18","pubTimestamp":1778577534,"startTime":"0","endTime":"0","summary":"证券之星消息，近日百济神州披露，截至2026年3月31日公司股东户数为3.52万户，较12月31日增加2161.0户，增幅为6.53%。在化学制药行业个股中，百济神州股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.58万户。从股价来看，2025年12月31日至2026年3月31日，百济神州区间跌幅为13.03%，在此期间股东户数增加2161.0户，增幅为6.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200029275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1588","LU1303224171.USD","BK1500","BK1583","688235","LU1251922891.USD","LU1770034418.SGD","LU2328871848.SGD","LU0588546209.SGD","LU0307460666.USD","LU1719994722.HKD","LU1969619763.USD","BK0239","06160"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0011},{"period":"3month","weight":-0.071},{"period":"6month","weight":-0.1182},{"period":"1year","weight":0.237},{"period":"ytd","weight":0.0073}],"compareEarnings":[{"period":"1week","weight":-0.0126},{"period":"1month","weight":-0.023},{"period":"3month","weight":-0.0399},{"period":"6month","weight":-0.0205},{"period":"1year","weight":0.0832},{"period":"ytd","weight":-0.0118}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.04108},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007027},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}